159 Phase II trial of gemcitabine in combination with cisplatin and ifosfamide in advanced non-small cell lung cancer (NSCLC)
暂无分享,去创建一个
P. Sánchez‐Rovira | M. A. Moreno | A. Lozano | B. Medina | N. Mohedano | M. Fernández | E. Flores-Gonzalez
暂无分享,去创建一个
P. Sánchez‐Rovira | M. A. Moreno | A. Lozano | B. Medina | N. Mohedano | M. Fernández | E. Flores-Gonzalez